Investigating the Association Between Serum Testosterone Level and Metabolic Profile in Patients with Non-alcoholic Fatty Liver Disease: A Cross-sectional Study

Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 53

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_NHJ-8-1_004

تاریخ نمایه سازی: 27 مرداد 1403

Abstract:

Background: Considering the impact of serum testosterone levels on metabolic diseases, this study aims to investigate testosterone levels in patients with non-alcoholic fatty liver disease (NAFLD).   Methods: A prospective cohort study was performed between two groups: Group A, ۵۸ patients with NAFLD, and Group B, ۵۹ patients without NAFLD. Fatty liver was diagnosed based on Abdominal ultrasound using the Hamaguchi score. Blood specimens were obtained from all patients between ۸ and ۱۰ AM and analyzed for testosterone, aspartate aminotransferase, alanine transaminase, serum lipid profile, ferritin, and fasting blood sugar levels. Results: The mean weight and body mass index were significantly higher in the study group (Group A) (P-value = ۰.۰۰۰۱). The mean aspartate aminotransferase and alanine transaminase were ۳۷.۷ and ۵۶.۶ in Group A, respectively, and were significantly higher than the control group (Group B) (P-value = ۰.۰۰۰۱). Fasting blood sugar, lipid profile, and serum ferritin differed between the two groups. The mean serum testosterone level was ۳.۳۸ ± ۰.۷۲ in Group A and ۴.۷۹ ± ۰.۸۸ ng/dL in Group B (P-value = ۰.۰۰۰۱). The testosterone level negatively correlated with age and hepatic steatosis grade (P-value = ۰.۰۰۰۱). However, it has a weak and positive correlation with BMI (P-value = ۰.۴۵۴). Conclusion: This study revealed that the patients with NAFLD had a significantly lower level of testosterone compared to the other individuals. This study highlights the role of NAFLD as a potential cause of hypogonadism in men.

Keywords:

Fatty Liver , Non-alcoholic fatty liver disease , NAFLD , Testosterone , Hypogonadism.

Authors

Hossein Nezhadjavad

School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Reza Dehghaniathar

Urology department, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.

Asaad Moradi

Urology department, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Alba LM, Lindor K. Non‐alcoholic fatty liver disease. Aliment Pharmacol ...
  • Tilg H, Moschen AR. Evolution of inflammation in non-alcoholic fatty ...
  • Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for ...
  • Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty ...
  • Machado M, Cortez-Pinto H. Non-alcoholic steatohepatitis and metabolic syndrome. Curr ...
  • Mintziori G, Poulakos P, Tsametis C, Goulis DG. Hypogonadism and ...
  • Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, ...
  • Bornstein SR, Rutkowski H, Vrezas I. Cytokines and steroidogenesis. Mol ...
  • Herman AP, Krawczyńska A, Bochenek J, Dobek E, Herman A, ...
  • Weng, C., Shao, Z., Xiao, M., Song, M., Zhao, Y., ...
  • Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, ...
  • Park JM, Lee HS, Oh J, Lee YJ. Serum Testosterone ...
  • Nikolaenko L, Jia Y, Wang C, Diaz-Arjonilla M, Yee JK, ...
  • Polyzos SA, Mousiolis A, Mintziori G, Goulis DG. Non-alcoholic fatty ...
  • نمایش کامل مراجع